A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119] |
Rosenberg, Jonathan |
- Bladder Cancer
- Kidney Cancer
|
Use of High-Resolution Structural MRI to Assess Changes in Brain Structure Related to Chemotherapy in Patients with Non-Small Cell Lung Cancer: A Prospective Study
[Protocol 11-145] |
Root, James |
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Survivorship
|
A Phase II Study of Veliparib plus Temozolomide, Veliparib plus Carboplatin and Paclitaxel, or Carboplatin and Paclitaxel with Placebo in Patients with BRCA Mutations and Metastatic Breast Cancer
[Protocol 12-122] |
Robson, Mark |
|
Understanding Decision-Making Processes for Undergoing Genetic Testing Among Women with Newly Diagnosed Breast Cancer
[Protocol 11-086] |
Robson, Mark |
- Breast Cancer
- Hereditary Cancer & Genetics
|
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 12-116] |
Roberts, Stephen |
- Neuroblastoma
- Sarcomas
- Osteosarcoma
- Soft Tissue Sarcoma
|
A Phase Ib Study of Combination Therapy with MSC1936369B and SAR245409 in Patients with Locally Advanced or Metastatic Solid Tumors
[Protocol 12-107] |
Rizvi, Naiyer |
|
A Phase II Study of BMS-936558 in Patients with Previously Treated Advanced Squamous Cell Lung Cancer
[Protocol 12-284] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase III Study of BMS-936558 versus Docetaxel in Patients with Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
[Protocol 12-252] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of BMS-936558 with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase III Study of BMS-936558 versus Docetaxel in Previously Treated Advanced Squamous Cell Lung Cancer
[Protocol 12-203] |
Rizvi, Naiyer |
|
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283] |
Rizvi, Naiyer |
- Lung Cancer, Non-Small Cell
- Melanoma
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
- Solid Tumors
|
A Prospective Study to Determine if Variations in Tissue Oxygenation Are Associated with Leak Rates after Esophagectomy
[Protocol 11-192] |
Rizk, Nabil |
|
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Cancer
[Protocol 11-037] |
Rizk, Nabil |
|
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003] |
Rimner, Andreas |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111] |
Rimner, Andreas |
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
|
A Phase I Study of SNX-5422 plus Erlotinib in Patients with Lung Cancer that Has Grown on Erlotinib Therapy
[Protocol 13-035] |
Riely, Gregory |
- Lung Cancer, Non-Small Cell
|
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222] |
Riely, Gregory |
- Lung Cancer, Non-Small Cell
|
Phase I Study of PF-02341066 in People with Advanced Cancer
[Protocol 07-157] |
Riely, Gregory |
|
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers
[Protocol 12-015] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
